BDB-001

· Staidson (Beijing) Biopharmaceuticals Co., Ltd

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for BDB-001, covering 2023-08-29 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: BDB-001 Phase III Trial in ANCA-Associated Vasculitis [Phase 3]